Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Research Frontiers (REFR) over the last 10 years, with Q3 2025 value amounting to $1.1 million.

  • Research Frontiers' Cash & Equivalents fell 3140.78% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 3140.78%. This contributed to the annual value of $2.0 million for FY2024, which is 1945.8% down from last year.
  • Per Research Frontiers' latest filing, its Cash & Equivalents stood at $1.1 million for Q3 2025, which was down 3140.78% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Research Frontiers' Cash & Equivalents ranged from a high of $4.8 million in Q3 2022 and a low of $206524.0 during Q3 2021
  • For the 5-year period, Research Frontiers' Cash & Equivalents averaged around $2.1 million, with its median value being $1.9 million (2024).
  • In the last 5 years, Research Frontiers' Cash & Equivalents plummeted by 9620.37% in 2021 and then surged by 222418.51% in 2022.
  • Research Frontiers' Cash & Equivalents (Quarter) stood at $269964.0 in 2021, then surged by 1467.21% to $4.2 million in 2022, then tumbled by 41.48% to $2.5 million in 2023, then fell by 19.46% to $2.0 million in 2024, then tumbled by 43.32% to $1.1 million in 2025.
  • Its Cash & Equivalents was $1.1 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.4 million in Q1 2025.